Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study.

"Declarations Ethics approval and consent to participateThe study protocol was approved by the Ethics Committees of Beijing Tiantan Hospital (IRB approval number: KY2017-010-01) and Lishui Hospital (IRB approval number: 2016-42). Informed consent was obtained from all participants prior to enrollment. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This study was supported by grants from the National Key R&D Program of China (2022YFC3602505), the National Natural Science Foundation of China (82073648), and the Ministry of Science and Technology of the People’s Republic of China (2016YFC0901002), Key Science & Technologies R&D Program of Lishui City (2019ZDYF18), Zhejiang provincial program for the Cultivation of High-level Innovative Health talents, and AstraZeneca Investment (China) Co., Ltd. The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript."